Cargando…
Amplicon and Metagenomic Analysis of Middle East Respiratory Syndrome (MERS) Coronavirus and the Microbiome in Patients with Severe MERS
Middle East respiratory syndrome coronavirus (MERS-CoV) is a zoonotic infection that emerged in the Middle East in 2012. Symptoms range from mild to severe and include both respiratory and gastrointestinal illnesses. The virus is mainly present in camel populations with occasional zoonotic spill ove...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386452/ https://www.ncbi.nlm.nih.gov/pubmed/34287009 http://dx.doi.org/10.1128/mSphere.00219-21 |
_version_ | 1783742265177407488 |
---|---|
author | Aljabr, Waleed Alruwaili, Muhannad Penrice-Randal, Rebekah Alrezaihi, Abdulrahman Harrison, Abbie Jasmine Ryan, Yan Bentley, Eleanor Jones, Benjamin Alhatlani, Bader Y. AlShahrani, Dayel Mahmood, Zana Rickett, Natasha Y. Alosaimi, Bandar Naeem, Asif Alamri, Saad Alsran, Hadel Hamed, Maaweya E. Dong, Xiaofeng Assiri, Abdullah M. Alrasheed, Abdullah R. Hamza, Muaawia Carroll, Miles W. Gemmell, Matthew Darby, Alistair Donovan-Banfield, I’ah Stewart, James P. Matthews, David A. Davidson, Andrew D. Hiscox, Julian A. |
author_facet | Aljabr, Waleed Alruwaili, Muhannad Penrice-Randal, Rebekah Alrezaihi, Abdulrahman Harrison, Abbie Jasmine Ryan, Yan Bentley, Eleanor Jones, Benjamin Alhatlani, Bader Y. AlShahrani, Dayel Mahmood, Zana Rickett, Natasha Y. Alosaimi, Bandar Naeem, Asif Alamri, Saad Alsran, Hadel Hamed, Maaweya E. Dong, Xiaofeng Assiri, Abdullah M. Alrasheed, Abdullah R. Hamza, Muaawia Carroll, Miles W. Gemmell, Matthew Darby, Alistair Donovan-Banfield, I’ah Stewart, James P. Matthews, David A. Davidson, Andrew D. Hiscox, Julian A. |
author_sort | Aljabr, Waleed |
collection | PubMed |
description | Middle East respiratory syndrome coronavirus (MERS-CoV) is a zoonotic infection that emerged in the Middle East in 2012. Symptoms range from mild to severe and include both respiratory and gastrointestinal illnesses. The virus is mainly present in camel populations with occasional zoonotic spill over into humans. The severity of infection in humans is influenced by numerous factors, and similar to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), underlying health complications can play a major role. Currently, MERS-CoV and SARS-CoV-2 are coincident in the Middle East and thus a rapid way of sequencing MERS-CoV to derive genotype information for molecular epidemiology is needed. Additionally, complicating factors in MERS-CoV infections are coinfections that require clinical management. The ability to rapidly characterize these infections would be advantageous. To rapidly sequence MERS-CoV, an amplicon-based approach was developed and coupled to Oxford Nanopore long read length sequencing. This and a metagenomic approach were evaluated with clinical samples from patients with MERS. The data illustrated that whole-genome or near-whole-genome information on MERS-CoV could be rapidly obtained. This approach provided data on both consensus genomes and the presence of minor variants, including deletion mutants. The metagenomic analysis provided information of the background microbiome. The advantage of this approach is that insertions and deletions can be identified, which are the major drivers of genotype change in coronaviruses. IMPORTANCE Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in late 2012 in Saudi Arabia. The virus is a serious threat to people not only in the Middle East but also in the world and has been detected in over 27 countries. MERS-CoV is spreading in the Middle East and neighboring countries, and approximately 35% of reported patients with this virus have died. This is the most severe coronavirus infection so far described. Saudi Arabia is a destination for many millions of people in the world who visit for religious purposes (Umrah and Hajj), and so it is a very vulnerable area, which imposes unique challenges for effective control of this epidemic. The significance of our study is that clinical samples from patients with MERS were used for rapid in-depth sequencing and metagenomic analysis using long read length sequencing. |
format | Online Article Text |
id | pubmed-8386452 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-83864522021-09-09 Amplicon and Metagenomic Analysis of Middle East Respiratory Syndrome (MERS) Coronavirus and the Microbiome in Patients with Severe MERS Aljabr, Waleed Alruwaili, Muhannad Penrice-Randal, Rebekah Alrezaihi, Abdulrahman Harrison, Abbie Jasmine Ryan, Yan Bentley, Eleanor Jones, Benjamin Alhatlani, Bader Y. AlShahrani, Dayel Mahmood, Zana Rickett, Natasha Y. Alosaimi, Bandar Naeem, Asif Alamri, Saad Alsran, Hadel Hamed, Maaweya E. Dong, Xiaofeng Assiri, Abdullah M. Alrasheed, Abdullah R. Hamza, Muaawia Carroll, Miles W. Gemmell, Matthew Darby, Alistair Donovan-Banfield, I’ah Stewart, James P. Matthews, David A. Davidson, Andrew D. Hiscox, Julian A. mSphere Research Article Middle East respiratory syndrome coronavirus (MERS-CoV) is a zoonotic infection that emerged in the Middle East in 2012. Symptoms range from mild to severe and include both respiratory and gastrointestinal illnesses. The virus is mainly present in camel populations with occasional zoonotic spill over into humans. The severity of infection in humans is influenced by numerous factors, and similar to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), underlying health complications can play a major role. Currently, MERS-CoV and SARS-CoV-2 are coincident in the Middle East and thus a rapid way of sequencing MERS-CoV to derive genotype information for molecular epidemiology is needed. Additionally, complicating factors in MERS-CoV infections are coinfections that require clinical management. The ability to rapidly characterize these infections would be advantageous. To rapidly sequence MERS-CoV, an amplicon-based approach was developed and coupled to Oxford Nanopore long read length sequencing. This and a metagenomic approach were evaluated with clinical samples from patients with MERS. The data illustrated that whole-genome or near-whole-genome information on MERS-CoV could be rapidly obtained. This approach provided data on both consensus genomes and the presence of minor variants, including deletion mutants. The metagenomic analysis provided information of the background microbiome. The advantage of this approach is that insertions and deletions can be identified, which are the major drivers of genotype change in coronaviruses. IMPORTANCE Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in late 2012 in Saudi Arabia. The virus is a serious threat to people not only in the Middle East but also in the world and has been detected in over 27 countries. MERS-CoV is spreading in the Middle East and neighboring countries, and approximately 35% of reported patients with this virus have died. This is the most severe coronavirus infection so far described. Saudi Arabia is a destination for many millions of people in the world who visit for religious purposes (Umrah and Hajj), and so it is a very vulnerable area, which imposes unique challenges for effective control of this epidemic. The significance of our study is that clinical samples from patients with MERS were used for rapid in-depth sequencing and metagenomic analysis using long read length sequencing. American Society for Microbiology 2021-07-21 /pmc/articles/PMC8386452/ /pubmed/34287009 http://dx.doi.org/10.1128/mSphere.00219-21 Text en Copyright © 2021 Aljabr et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Article Aljabr, Waleed Alruwaili, Muhannad Penrice-Randal, Rebekah Alrezaihi, Abdulrahman Harrison, Abbie Jasmine Ryan, Yan Bentley, Eleanor Jones, Benjamin Alhatlani, Bader Y. AlShahrani, Dayel Mahmood, Zana Rickett, Natasha Y. Alosaimi, Bandar Naeem, Asif Alamri, Saad Alsran, Hadel Hamed, Maaweya E. Dong, Xiaofeng Assiri, Abdullah M. Alrasheed, Abdullah R. Hamza, Muaawia Carroll, Miles W. Gemmell, Matthew Darby, Alistair Donovan-Banfield, I’ah Stewart, James P. Matthews, David A. Davidson, Andrew D. Hiscox, Julian A. Amplicon and Metagenomic Analysis of Middle East Respiratory Syndrome (MERS) Coronavirus and the Microbiome in Patients with Severe MERS |
title | Amplicon and Metagenomic Analysis of Middle East Respiratory Syndrome (MERS) Coronavirus and the Microbiome in Patients with Severe MERS |
title_full | Amplicon and Metagenomic Analysis of Middle East Respiratory Syndrome (MERS) Coronavirus and the Microbiome in Patients with Severe MERS |
title_fullStr | Amplicon and Metagenomic Analysis of Middle East Respiratory Syndrome (MERS) Coronavirus and the Microbiome in Patients with Severe MERS |
title_full_unstemmed | Amplicon and Metagenomic Analysis of Middle East Respiratory Syndrome (MERS) Coronavirus and the Microbiome in Patients with Severe MERS |
title_short | Amplicon and Metagenomic Analysis of Middle East Respiratory Syndrome (MERS) Coronavirus and the Microbiome in Patients with Severe MERS |
title_sort | amplicon and metagenomic analysis of middle east respiratory syndrome (mers) coronavirus and the microbiome in patients with severe mers |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386452/ https://www.ncbi.nlm.nih.gov/pubmed/34287009 http://dx.doi.org/10.1128/mSphere.00219-21 |
work_keys_str_mv | AT aljabrwaleed ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers AT alruwailimuhannad ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers AT penricerandalrebekah ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers AT alrezaihiabdulrahman ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers AT harrisonabbiejasmine ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers AT ryanyan ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers AT bentleyeleanor ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers AT jonesbenjamin ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers AT alhatlanibadery ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers AT alshahranidayel ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers AT mahmoodzana ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers AT rickettnatashay ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers AT alosaimibandar ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers AT naeemasif ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers AT alamrisaad ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers AT alsranhadel ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers AT hamedmaaweyae ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers AT dongxiaofeng ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers AT assiriabdullahm ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers AT alrasheedabdullahr ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers AT hamzamuaawia ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers AT carrollmilesw ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers AT gemmellmatthew ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers AT darbyalistair ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers AT donovanbanfieldiah ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers AT stewartjamesp ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers AT matthewsdavida ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers AT davidsonandrewd ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers AT hiscoxjuliana ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers |